‘FSA research encouraging but not conclusive – there’s still work to be done’ says the ABI

But the Association agrees that more work has to be done to make sure that this sales process is safe for consumers.

It is also clear that decisions about price caps for Sandler products can only be made once the economics of the sales process are settled.

Speaking about the findings Mary Francis, Director General of ABI said:

"The insurance industry has been happy to help with this research. It is important that our customers have confidence in the sales process for Sandler products, and we will continue to work with the FSA on the next stage of their research."